Brain Metabolic Dysfunction in Capgras Delusion During Alzheimer's Disease: A Positron Emission Tomography Study

被引:7
|
作者
Jedidi, H. [1 ,2 ]
Daury, N. [3 ]
Capa, R. [3 ]
Bahri, M. A. [1 ]
Collette, F. [1 ,3 ]
Feyers, D. [1 ]
Bastin, C. [1 ,2 ]
Maquet, P. [1 ]
Salmon, E. [1 ,2 ]
机构
[1] Univ Liege, Ctr Rech Cyclotron, B-4000 Liege, Belgium
[2] Univ Liege, Dept Clin Sci, Neuroimagerie Troubles Memoire & Revalidat Cognit, B-4000 Liege, Belgium
[3] Univ Liege, Dept Psychol Cognit & Comportement, B-4000 Liege, Belgium
关键词
capgras; delusion of misidentification; face recognition; brain glucose metabolism; neuroimaging; MEDIAL PREFRONTAL CORTEX; MISIDENTIFICATION SYNDROMES; FACE RECOGNITION; NEURAL SYSTEMS; SELF; FAMILIARITY; KNOWLEDGE; AWARENESS; DEMENTIA; PROSOPAGNOSIA;
D O I
10.1177/1533317513495105
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Capgras delusion is characterized by the misidentification of people and by the delusional belief that the misidentified persons have been replaced by impostors, generally perceived as persecutors. Since little is known regarding the neural correlates of Capgras syndrome, the cerebral metabolic pattern of a patient with probable Alzheimer's disease (AD) and Capgras syndrome was compared with those of 24-healthy elderly participants and 26 patients with AD without delusional syndrome. Comparing the healthy group with the AD group, the patient with AD had significant hypometabolism in frontal and posterior midline structures. In the light of current neural models of face perception, our patients with Capgras syndrome may be related to impaired recognition of a familiar face, subserved by the posterior cingulate/precuneus cortex, and impaired reflection about personally relevant knowledge related to a face, subserved by the dorsomedial prefrontal cortex.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 50 条
  • [1] Brain metabolic dysfunction in Capgras syndrome during Alzheimer's disease: a positron emission tomography study
    Jedidi, H.
    Daury, N.
    Capa, R.
    Bahri, M. A.
    Collette, F.
    Feyers, D.
    Bastin, C.
    Maquet, P.
    Salmon, E.
    JOURNAL OF NEUROLOGY, 2013, 260 : S214 - S214
  • [2] Positron emission tomography metabolic correlates of apathy in Alzheimer disease
    Marshall, Gad A.
    Monserratt, Lorena
    Harwood, Dylan
    Mandelkern, Mark
    Cummings, Jeffrey L.
    Sultzer, David L.
    ARCHIVES OF NEUROLOGY, 2007, 64 (07) : 1015 - 1020
  • [3] Positron emission tomography diagnosis of Alzheimer's disease
    Coleman, RE
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2005, 15 (04) : 837 - +
  • [4] Positron Emission Tomography Diagnosis of Alzheimer's Disease
    Coleman, R. Edward
    PET CLINICS, 2007, 2 (01) : 25 - 34
  • [5] Resveratrol in Alzheimer's disease: a PIB positron emission tomography/computed tomography study
    Damian, A.
    De la Fuente, A.
    Castellano, G.
    Savio, E.
    Buccino, P.
    Aguiar, B.
    Quagliata, A.
    Cano, F.
    Gonzalez, M.
    Dansilio, S.
    Kmaid, A.
    Savio, I.
    Engler, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S135 - S135
  • [6] The psychotic phenomenon in probable Alzheimer's disease: A positron emission tomography study
    Lopez, OL
    Smith, G
    Becker, JT
    Meltzer, CC
    DeKosky, ST
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 13 (01) : 50 - 55
  • [7] Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease
    Kjell Någren
    Christer Halldin
    Juha O. Rinne
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1575 - 1593
  • [8] Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease
    Nagren, Kjell
    Halldin, Christer
    Rinne, Juha O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (08) : 1575 - 1593
  • [9] Positron-emission tomography and Alzheimer's disease - Reply
    Reiman, EM
    Caselli, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03): : 207 - 208
  • [10] Tau positron emission tomography in preclinical Alzheimer's disease
    Insel, Philip S.
    Young, Christina B.
    Aisen, Paul S.
    Johnson, Keith A.
    Sperling, Reisa A.
    Mormino, Elizabeth C.
    Donohue, Michael C.
    BRAIN, 2023, 146 (02) : 700 - 711